AGILI-C
Device
Bioventus LLC
Total Payments
$126,393
Transactions
35
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $126,393 | 35 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $125,305 | 26 | 99.1% |
| Consulting Fee | $1,089 | 9 | 0.9% |
Payments by Type
Research
$125,305
26 transactions
General
$1,089
9 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Agili-C Post Approval | Bioventus LLC | $66,521 | 0 |
| Agili-C Post-Approval | Bioventus LLC | $37,545 | 0 |
| CartiHeal Post-Approval | Bioventus LLC | $21,238 | 0 |
Ad
Manufacturing Companies
- Bioventus LLC $126,393
Product Information
- Type Device
- Total Payments $126,393
- Total Doctors 3
- Transactions 35
About AGILI-C
AGILI-C is a device associated with $126,393 in payments to 3 healthcare providers, recorded across 35 transactions in the CMS Open Payments database. The primary manufacturer is Bioventus LLC.
Payment data is available from 2022 to 2022. In 2022, $126,393 was paid across 35 transactions to 3 doctors.
The most common payment nature for AGILI-C is "Unspecified" ($125,305, 99.1% of total).
AGILI-C is associated with 3 research studies, including "Agili-C Post Approval" ($66,521).